Tobacco control

Revolution or redux? Assessing IQOS through a precursor product.

Tobacco control

Elias J, Dutra LM, St Helen G, Ling PM

Heated tobacco product regulation under US law and the FCTC.

Tobacco control

Lempert LK, Glantz SA

Researching policy impacts.

Tobacco control

Malone RE

Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product.

Tobacco control

Max WB, Sung HY, Lightwood J, Wang Y, Yao T

Philip Morris International-funded 'Foundation for a Smoke-Free World': analysing its claims of independence.

Tobacco control

van der Eijk Y, Bero LA, Malone RE

Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims.

Tobacco control

Popova L, Lempert LK, Glantz SA

Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control.

Tobacco control

Bialous SA, Glantz SA

Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke.

Tobacco control

Nabavizadeh P, Liu J, Havel CM, Ibrahim S, Derakhshandeh R, Jacob Iii P, Springer ML

Keeping tobacco cheap: how tobacco companies undermine government tax measures.

Tobacco control

Malone RE

Assessment of industry data on pulmonary and immunosuppressive effects of IQOS.

Tobacco control

Moazed F, Chun L, Matthay MA, Calfee CS, Gotts J

Pages